First-Line Bladder Cancer Trial Makes the Case for HER2 Screening

(MedPage Today) — BERLIN — A Chinese trial that screened advanced urothelial cancer patients for HER2-expression demonstrated a large survival benefit with a novel chemotherapy-free combination in the first-line setting, though it’s unclear…

Source link : https://www.medpagetoday.com/meetingcoverage/esmo/118060

Author :

Publish date : 2025-10-21 15:21:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

First-Line Bladder Cancer Trial Makes the Case for HER2 Screening

Impella Controller Recall; AI-Enabled Risk Tool; BP Control and Retina Changes

Add-On Radioligand Therapy Slows Metastatic Hormone-Sensitive Prostate Cancer

Related Posts

Takotsubo Syndrome Goes Pop: Spanish Singer Rosalía’s Twist

Complex Pancreatic Surgery Often Done at Low-Volume Centers

Preexisting Autoimmunity Tied to Better CAR T-Cell Outcomes

Bone Drug Fails to Stop Muscle Loss Post-Bariatric Surgery

Scientists discover why type 1 diabetes is worse in children

Fossil fuel emissions rise again – but China’s are levelling off

Takotsubo Syndrome Goes Pop: Spanish Singer Rosalía’s Twist

Complex Pancreatic Surgery Often Done at Low-Volume Centers

Preexisting Autoimmunity Tied to Better CAR T-Cell Outcomes

Bone Drug Fails to Stop Muscle Loss Post-Bariatric Surgery

Scientists discover why type 1 diabetes is worse in children

Fossil fuel emissions rise again – but China’s are levelling off

More Kids Have High Blood Pressure, Many May Be Missed by In-Office Screening Alone

At Hush-Hush MAHA Summit, Vance Praises RFK Jr. for Defying Convention

Categories

Archives